UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

BeEAM conditioning regimen is a safe, efficacious and economical alternative to BEAM chemotherapy

Scientific reports, 2021-07, Vol.11 (1), p.14071-14071, Article 14071

2021

Volltextzugriff (PDF)

Vitamin B12 deficiency and metabolism-mediated thrombotic microangiopathy (MM-TMA)

Transfusion and apheresis science, 2020-02, Vol.59 (1), p.102717-102717, Article 102717

2020

Volltextzugriff (PDF)

Revised 15-item MDS-specific frailty scale maintains prognostic potential

Leukemia, 2020-12, Vol.34 (12), p.3434-3438

2020

Volltextzugriff (PDF)

High transferrin saturation predicts inferior clinical outcomes in patients with myelodysplastic syndromes

Haematologica (Roma), 2023-02, Vol.108 (2), p.532-542

2023

Volltextzugriff (PDF)

Real World Clinical Experience of Biosimilar G-CSF (Grastofil) for Autologous Peripheral Blood Stem Cell Mobilization: Single Center Experience in Canada Following Early Adoption

Current oncology (Toronto), 2021-04, Vol.28 (3), p.1571-1580

2021

Volltextzugriff (PDF)

Morphological Clues of Acute Monocytic Leukemia in COVID-19-Induced Transient Leukoerythroblastic Reaction with Monocytosis

Hematology reports, 2024-05, Vol.16 (2), p.331-335

2024

Volltextzugriff (PDF)

Validation of next-generation sequencing-based chimerism testing for accurate detection and monitoring of engraftment in hematopoietic stem cell transplantation

Frontiers in genetics, 2023-10, Vol.14, p.1282947-1282947

2023

Volltextzugriff (PDF)

Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development

Current oncology (Toronto), 2024-03, Vol.31 (3), p.1426-1444

2024

Volltextzugriff (PDF)

Impact of Transfusion on Cancer Growth and Outcome

Cancer Growth and Metastasis, 2016-01, Vol.2016 (2016), p.1-8

2016

Volltextzugriff (PDF)

Evaluation of high cut Dega osteotomy for management of developmental hip dysplasia in children

SVU - International Journal of Medical Sciences (Online), 2021-08, Vol.4 (2), p.246-256

2021

Volltextzugriff (PDF)

Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease

The New England journal of medicine, 2020-05, Vol.382 (19), p.1800-1810

2020

Volltextzugriff (PDF)

Autologous Stem Cell Transplantation for Transformed Lymphoma: Single-Center Experience

Lymphoma and Chronic Lymphocytic Leukemias, 2016-08, Vol.2016 (2016), p.35-39

2016

Volltextzugriff (PDF)

Liberal Versus Restrictive Red Blood Cell Transfusion Thresholds in Hematopoietic Cell Transplantation: A Randomized, Open Label, Phase III, Noninferiority Trial

Journal of clinical oncology, 2020-05, Vol.38 (13), p.1463-1473

2020

Volltextzugriff (PDF)

Retrospective, Multi-Center Analysis of Ruxolitinib Tapering after Successful Treatment of Steroid Refractory Chronic Graft Versus Host Disease

Blood, 2023-11, Vol.142 (Supplement 1), p.4934-4934

2023

Volltextzugriff (PDF)

Real-world experience with ruxolitinib therapy for steroid-refractory acute graft versus host disease

Bone marrow transplantation (Basingstoke), 2024-06, Vol.59 (6), p.759-764

2024

Volltextzugriff (PDF)

Real-World Experience with Ruxolitinib Therapy for Steroid Refractory Acute Graft Versus Host Disease

Blood, 2022-11, Vol.140 (Supplement 1), p.7662-7663

2022

Volltextzugriff (PDF)

Propensity score matching analysis comparing the efficacy of Ruxolitinib to historical controls in second-line or beyond treatment for chronic GvHD after steroid failure

Bone marrow transplantation (Basingstoke), 2023-09, Vol.58 (9), p.1024-1032

2023

Volltextzugriff (PDF)

Update of Multicenter, Retrospective Evaluation of Overall Response and Failure Free Survival Following Ruxolitinib Therapy for Heavily Pre-Treated Chronic Gvhd Patients with Steroid-Failure: A Proposal of Risk Score Model for Failure-Free Survival

Blood, 2021-11, Vol.138 (Supplement 1), p.3905-3905

2021

Volltextzugriff (PDF)

Propensity Score Matching Analysis Comparing Ruxolitinib Vs Historical Controls in 2 nd Line or Beyond Treatment for Chronic Gvhd after Therapy Failure

Blood, 2021-11, Vol.138 (Supplement 1), p.1805-1805

2021

Volltextzugriff (PDF)

Transplant-associated thrombotic microangiopathy: Diagnostic challenges and management strategies

Transfusion and apheresis science, 2019-06, Vol.58 (3), p.347-350

2019

Volltextzugriff (PDF)

Biosimilar G-CSF Versus Originator G-CSF for Autologous Peripheral Blood Stem Cell Mobilization: A Comparative Analysis of Mobilization and Engraftment

Blood, 2018-11, Vol.132 (Supplement 1), p.3345-3345

2018

Volltextzugriff (PDF)

The Impact from Frontline CLL Chemo Immunotherapy Regimen Outcomes Based on Patient Tolerability

Blood, 2018-11, Vol.132 (Supplement 1), p.5551-5551

2018

Volltextzugriff (PDF)

Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial

The Lancet. Haematology, 2019-09, Vol.6 (9), p.e459-e469

2019

Volltextzugriff (PDF)

1 – 25 von 76

Suche als RSS-Feed

Aktive Filter

ThemaMedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(67)

Publikationsform

Artikel
(69)
Buchkapitel
(7)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(36)
Life Sciences & Biomedicine
(30)
Hematology
(20)
Humans
(17)
Oncology
(11)
Female
(9)
Male
(8)
Aged
(7)
Transplantation
(7)
Adult
(6)
Middle Aged
(6)
Myelodysplastic Syndromes
(6)
Patients
(6)
Graft-Versus-Host Reaction
(5)
Immunology
(5)
Survival
(5)
Graft Vs Host Disease - Etiology
(4)
Hematology, Oncology And Palliative Medicine
(4)
Hematopoietic Stem Cell Transplantation - Adverse Effects
(4)
Hematopoietic Stem Cell Transplantation - Methods
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

BeEAM conditioning regimen is a safe, efficacious and economical alternative to BEAM chemotherapy

Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial

Vitamin B12 deficiency and metabolism-mediated thrombotic microangiopathy (MM-TMA)

Revised 15-item MDS-specific frailty scale maintains prognostic potential

High transferrin saturation predicts inferior clinical outcomes in patients with myelodysplastic syndromes

Real World Clinical Experience of Biosimilar G-CSF (Grastofil) for Autologous Peripheral Blood Stem Cell Mobilization: Single Center Experience in Canada Following Early Adoption

Morphological Clues of Acute Monocytic Leukemia in COVID-19-Induced Transient Leukoerythroblastic Reaction with Monocytosis

Validation of next-generation sequencing-based chimerism testing for accurate detection and monitoring of engraftment in hematopoietic stem cell transplantation

Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development

Impact of Transfusion on Cancer Growth and Outcome

Evaluation of high cut Dega osteotomy for management of developmental hip dysplasia in children

Thymoglobulin Decreases the Need for Immunosuppression at 12 Months after Myeloablative and Nonmyeloablative Unrelated Donor Transplantation: CBMTG 0801, a Randomized, Controlled Trial

Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease

Autologous Stem Cell Transplantation for Transformed Lymphoma: Single-Center Experience

Liberal Versus Restrictive Red Blood Cell Transfusion Thresholds in Hematopoietic Cell Transplantation: A Randomized, Open Label, Phase III, Noninferiority Trial

Retrospective, Multi-Center Analysis of Ruxolitinib Tapering after Successful Treatment of Steroid Refractory Chronic Graft Versus Host Disease

Real-world experience with ruxolitinib therapy for steroid-refractory acute graft versus host disease

Real-World Experience with Ruxolitinib Therapy for Steroid Refractory Acute Graft Versus Host Disease

Propensity score matching analysis comparing the efficacy of Ruxolitinib to historical controls in second-line or beyond treatment for chronic GvHD after steroid failure

Update of Multicenter, Retrospective Evaluation of Overall Response and Failure Free Survival Following Ruxolitinib Therapy for Heavily Pre-Treated Chronic Gvhd Patients with Steroid-Failure: A Proposal of Risk Score Model for Failure-Free Survival

Propensity Score Matching Analysis Comparing Ruxolitinib Vs Historical Controls in 2 nd Line or Beyond Treatment for Chronic Gvhd after Therapy Failure

Transplant-associated thrombotic microangiopathy: Diagnostic challenges and management strategies

Biosimilar G-CSF Versus Originator G-CSF for Autologous Peripheral Blood Stem Cell Mobilization: A Comparative Analysis of Mobilization and Engraftment

The Impact from Frontline CLL Chemo Immunotherapy Regimen Outcomes Based on Patient Tolerability

Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial

Aktive Filter

Suchergebnisse filtern